{"id":"NCT01867164","sponsor":"Janssen-Cilag, S.A.","briefTitle":"A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis","officialTitle":"A Prospective, Open-Label, Comparative, Parallel Double-Arm, Multicentric Clinical Study to Evaluate the Efficacy of an Ovule With Triple Active Agents (Terconazole, Clindamycin, Fluocinolone) Administered Once Per Day for Three Days Versus an Ovule With Triple Active Agents (Metronidazole, Nystatin, Fluocinolone) Administered Once Per Day for Ten Days to Treat Secondary Vulvar/Vaginal Symptoms of Vaginitis/Infectious Vaginosis (Bacterial and/or Mycotic and/or Parasitic)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12","primaryCompletion":"2008-12","completion":"2008-12","firstPosted":"2013-06-03","resultsPosted":"2013-12-24","lastUpdate":"2013-12-24"},"enrollment":160,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Vaginitis","Infectious Vaginosis"],"interventions":[{"type":"DRUG","name":"Gynoclin V","otherNames":[]},{"type":"DRUG","name":"Vagitrol V","otherNames":[]}],"arms":[{"label":"Gynoclin V","type":"EXPERIMENTAL"},{"label":"Vagitrol V","type":"EXPERIMENTAL"}],"summary":"The purpose of this comparative study is to evaluate the efficacy of an ovule with triple active agents (terconazole, clindamycin and fluocinolone) versus another ovule with triple active agents (nystatin, metronidazole and fluocinolone) in the treatment of symptoms caused by the presence of vaginitis (inflammation of the vagina) or bacterial vaginosis (polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli).","primaryOutcome":{"measure":"Percentage of Participants With Presence or Absence of Symptoms 3 Days After Treatment","timeFrame":"3 days after treatment (Day 7 for Gynoclin V or Day 13 for Vagitrol V)","effectByArm":[{"arm":"Gynoclin V (Terconazole+Clindamycin+Fluocinolone Acetonide)","deltaMin":67.1,"sd":null},{"arm":"Vagitrol V (Metronidazole+Fluocinolone Acetonide+Nystatin)","deltaMin":79.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":2,"countries":["Mexico"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":81},"commonTop":["Fungal Infections","Headache"]}}